Insufficient scRNA-seq data for expression of IL12B at single-cell level.
Insufficient scRNA-seq data for expression of IL12B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 89% | 10.28 | 515 / 578 | 15% | 0.33 | 171 / 1155 |
kidney | 92% | 17.73 | 82 / 89 | 9% | 0.28 | 84 / 901 |
spleen | 85% | 10.08 | 205 / 241 | 0% | 0 | 0 / 0 |
thymus | 66% | 4.20 | 429 / 653 | 8% | 0.15 | 50 / 605 |
peripheral blood | 55% | 43.72 | 509 / 929 | 0% | 0 | 0 / 0 |
breast | 39% | 1.86 | 180 / 459 | 15% | 0.30 | 168 / 1118 |
skin | 49% | 2.18 | 888 / 1809 | 3% | 0.05 | 15 / 472 |
brain | 50% | 2.24 | 1333 / 2642 | 0% | 0.00 | 1 / 705 |
intestine | 43% | 2.33 | 412 / 966 | 1% | 0.02 | 7 / 527 |
prostate | 38% | 1.32 | 93 / 245 | 3% | 0.06 | 15 / 502 |
esophagus | 36% | 1.44 | 519 / 1445 | 2% | 0.02 | 3 / 183 |
bladder | 33% | 0.95 | 7 / 21 | 3% | 0.05 | 16 / 504 |
adipose | 36% | 1.40 | 433 / 1204 | 0% | 0 | 0 / 0 |
stomach | 30% | 0.90 | 107 / 359 | 2% | 0.04 | 7 / 286 |
uterus | 24% | 0.78 | 41 / 170 | 8% | 0.12 | 36 / 459 |
pancreas | 18% | 0.48 | 58 / 328 | 7% | 0.12 | 13 / 178 |
adrenal gland | 24% | 0.77 | 61 / 258 | 0% | 0 | 0 / 230 |
liver | 20% | 0.52 | 45 / 226 | 1% | 0.01 | 3 / 406 |
ovary | 20% | 0.55 | 36 / 180 | 0% | 0 | 0 / 430 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.46 | 5 / 29 |
heart | 15% | 0.43 | 133 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 13% | 0.48 | 177 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.22 | 5 / 45 |
muscle | 8% | 0.19 | 63 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0051135 | Biological process | positive regulation of NK T cell activation |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0010536 | Biological process | positive regulation of activation of Janus kinase activity |
GO_1903588 | Biological process | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO_0042098 | Biological process | T cell proliferation |
GO_0043382 | Biological process | positive regulation of memory T cell differentiation |
GO_2000318 | Biological process | positive regulation of T-helper 17 type immune response |
GO_0042832 | Biological process | defense response to protozoan |
GO_0032819 | Biological process | positive regulation of natural killer cell proliferation |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0032946 | Biological process | positive regulation of mononuclear cell proliferation |
GO_0051607 | Biological process | defense response to virus |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0030101 | Biological process | natural killer cell activation |
GO_0002862 | Biological process | negative regulation of inflammatory response to antigenic stimulus |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0034105 | Biological process | positive regulation of tissue remodeling |
GO_0050709 | Biological process | negative regulation of protein secretion |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0010224 | Biological process | response to UV-B |
GO_0034393 | Biological process | positive regulation of smooth muscle cell apoptotic process |
GO_0042093 | Biological process | T-helper cell differentiation |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0042088 | Biological process | T-helper 1 type immune response |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_0051142 | Biological process | positive regulation of NK T cell proliferation |
GO_0050671 | Biological process | positive regulation of lymphocyte proliferation |
GO_0032816 | Biological process | positive regulation of natural killer cell activation |
GO_0048662 | Biological process | negative regulation of smooth muscle cell proliferation |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0019953 | Biological process | sexual reproduction |
GO_0035722 | Biological process | interleukin-12-mediated signaling pathway |
GO_1900747 | Biological process | negative regulation of vascular endothelial growth factor signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0002860 | Biological process | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0002827 | Biological process | positive regulation of T-helper 1 type immune response |
GO_0032700 | Biological process | negative regulation of interleukin-17 production |
GO_2000330 | Biological process | positive regulation of T-helper 17 cell lineage commitment |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0002323 | Biological process | natural killer cell activation involved in immune response |
GO_0016477 | Biological process | cell migration |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0042509 | Biological process | regulation of tyrosine phosphorylation of STAT protein |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0070743 | Cellular component | interleukin-23 complex |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005829 | Cellular component | cytosol |
GO_0031906 | Cellular component | late endosome lumen |
GO_0043514 | Cellular component | interleukin-12 complex |
GO_0045519 | Molecular function | interleukin-23 receptor binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019955 | Molecular function | cytokine binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0042164 | Molecular function | interleukin-12 alpha subunit binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0004896 | Molecular function | cytokine receptor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005143 | Molecular function | interleukin-12 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL12B |
Protein name | Interleukin 12B Interleukin-12 subunit beta (IL-12B) (Cytotoxic lymphocyte maturation factor 40 kDa subunit) (CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2) (NKSF2) Truncated interleukin 12B |
Synonyms | NKSF2 |
Description | FUNCTION: Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC. .; FUNCTION: Associates with IL23A to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates the Jak-Stat signaling cascade, stimulates memory rather than naive T-cells and promotes production of pro-inflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis. . |
Accessions | A0A0C5Q0C2 P29460 ENST00000231228.3 ENST00000696751.1 A0A0C5PSA9 A0A0C5PS98 A0A8Q3SJ12 A0A0C5PMG4 A0A0C5PF30 A0A8Q3WML5 ENST00000696750.1 A0A0C5PP88 A0A0C5PF35 A0A0C5Q0B8 A0A0C5PP83 A0A0C5Q0C7 |